第 1 到 123 筆結果,共 123 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2013 | 14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma | Liu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Liang S.-M.; Chen S.-C.; Wang J.; CHIUN HSU ; YAO-MING WU ; Liou J.-Y. | PLoS ONE | 58 | 47 | |
2 | 2014 | 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma | Liu C.-C.; Jan Y.-J.; BOR-SHENG KO ; YAO-MING WU ; Liang S.-M.; Chen S.-C.; Lee Y.-M.; Liu T.-A.; Chang T.-C.; Wang J.; Shyue S.-K.; Sung L.-Y.; Liou J.-Y. | BMC Cancer | 29 | 26 | |
3 | 2012 | 14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3β | Chang T.-C.; Liu C.-C.; Hsing E.-W.; Liang S.-M.; Chi Y.-H.; Sung L.-Y.; Lin S.-P.; Shen T.-L.; BOR-SHENG KO ; Yen B.L.; Yet S.-F.; Wu K.K.; TANG-LONG SHEN ; LI-YING SUNG ; SHAU-PING LIN | PLoS ONE | 22 | 24 | |
4 | 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | WEN-CHIEN CHOU ; Chen, Chien-Yuan ; HSIN-AN HOU ; LIANG-IN LIN ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 54 | 51 | |
5 | 2002 | Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan | BOR-SHENG KO ; JIH-LUH TANG ; Lee F.-Y.; Liu M.-C.; Tsai W.; YAO-CHANG CHEN ; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN | American Journal of Hematology | 27 | 25 | |
6 | 2023 | Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan | Lee, Chun-Hui; Lin, Tzu-Chien; MING YAO ; Hsiao, Liang-Tsai; BOR-SHENG KO ; Liu, Chia-Jen; Chen, Tsai-Yun | Cancer medicine | |||
7 | 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | JIH-LUH TANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; LIANG-IN LIN ; HWEI-FANG TIEN | Blood | 281 | 255 | |
8 | 2023 | An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia | Tokaz, Molly C; Baldomero, Helen; Cowan, Andrew J; Saber, Wael; Greinix, Hildegard; Koh, Mickey B C; Kröger, Nicolaus; Mohty, Mohamad; Galeano, Sebastian; Okamoto, Shinichiro; Chaudhri, Naeem; Karduss, Amado J; Ciceri, Fabio; Colturato, Vergílio Antonio R; Corbacioglu, Selim; Elhaddad, Alaa; Force, Lisa M; Frutos, Cristóbal; León, Andrés Gómez-De; Hamad, Nada; Hamerschlak, Nelson; He, Naya; Ho, Aloysius; Huang, Xiao-Jun; Jacobs, Ben; Kim, Hee-Je; Iida, Minako; Lehmann, Leslie; de Latour, Regis Peffault; Percival, Mary-Elizabeth M; Perdomo, Martina; Rasheed, Walid; Schultz, Kirk R; Seber, Adriana; BOR-SHENG KO ; Simione, Anderson João; Srivastava, Alok; Szer, Jeff; Wood, William A; Kodera, Yoshihisa; Nagler, Arnon; Snowden, John A; Weisdorf, Daniel; Passweg, Jakob; Pasquini, Marcelo C; Sureda, Anna; Atsuta, Yoshiko; Aljurf, Mahmoud; Niederwieser, Dietger | Transplantation and cellular therapy | 3 | 1 | |
9 | 2021 | Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan – a population-based study | HUAI-HSUAN HUANG ; FEI-YUAN HSIAO ; Chen H.-M.; Wang C.-Y.; BOR-SHENG KO | British Journal of Haematology | 6 | 6 | |
10 | 2023 | Asia-Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia-Pacific region | Lao, Zhentang; Tse, Eric Wai Choi; Chuncharunee, Suporn; Kwong, Yok Lam; Wei, Andrew; BOR-SHENG KO ; Kim, Jin Seok; Ng, Soo Chin; Wang, Jianxiang; Goh, Yeow Tee | Asia-Pacific journal of clinical oncology | 0 | 0 | |
11 | 2021 | Association of tumor hydroxyindole o-methyltransferase and serum 5-methoxytryptophan with long-term survival of hepatocellular carcinoma | BOR-SHENG KO ; Liang S.-M.; Chang T.-C.; Wu J.-Y.; Lee P.-H.; Hsu Y.-J.; Kuo C.-C.; Liou J.-Y.; Wu K.K. | Cancers | 1 | 1 | |
12 | 2022 | Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients | Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; WEN-CHIEN CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; HWEI-FANG TIEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
13 | 2010 | Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B | BOR-SHENG KO ; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; CHIUN HSU ; Ying-Chun Shen ; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y. | Life Sciences | 39 | 36 | |
14 | 2016 | Breakthrough invasive fungal infection under the use of posaconazole and voriconazole | Lee S.-H.; HSIN-YUN SUN ; BOR-SHENG KO ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association | 1 | 1 | |
15 | 2022 | Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study | Wang Y.-H.; FENG-MING TIEN ; Tsai C.-H.; HUAI-HSUAN HUANG ; JIA-HAU LIU ; Liao X.-W.; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO | Cancer Reports | 1 | 1 | |
16 | 2014 | A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region | Soon S.-S.; Lopes G.; Lim H.-Y.; Wong-Rieger D.; Bahri S.; Hickinbotham L.; Jha A.; BOR-SHENG KO ; MacDonell D.; Pwu J.R.-F.; Shih R.; Sirachainan E.; Suh D.-C.; Wale J.; Zhang X.; Wee H.-L. | Orphanet Journal of Rare Diseases | 5 | 4 | |
17 | 2011 | Cardiac involvement of natural killer/T-cell lymphoma presenting with electrical storm after cardioverter-defibrillator implantation | Huang S.-H.; SONG-CHOU HSIEH ; BOR-SHENG KO ; YEN BIN LIU | Journal of Clinical Oncology | 7 | 6 | |
18 | 2017 | Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase | SHAN-CHI YU ; HUAI-HSUAN HUANG ; Li C.-C.; JIH-LUH TANG ; Lee Y.-H.; TSUI-LIEN MAO ; KUAN-TING KUO ; Lin C.-T.; JIA-HAU LIU ; BOR-SHENG KO ; MING YAO | Biology of Blood and Marrow Transplantation | 1 | 1 | |
19 | 2015 | Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives | HSIN-FU CHEN ; Yu C.-Y.; MEI-JOU CHEN ; Chou S.-H.; Chiang M.-S.; Chou W.-H.; BOR-SHENG KO ; HSIANG-PO HUANG ; Kuo H.-C.; HONG-NERNG HO | Cell Transplantation | 26 | 26 | |
20 | 2022 | A Chunking-for-Pooling Strategy for Cytometric Representation Learning for Automatic Hematologic Malignancy Classification | Li, Jeng-Lin; Lin, Yun-Chun; Wang, Yu-Fen; Monaghan, Sara A; BOR-SHENG KO ; Lee, Chi-Chun | IEEE journal of biomedical and health informatics | 0 | 0 | |
21 | 2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 7 | 4 | |
22 | 2008 | Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan | SHANG-JU WU ; Chen, Chien-Yuan ; Su I.-J.; JIH-LUH TANG ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Huang S.-Y.; MING YAO ; WOEI TSAY ; YAO-CHANG CHEN ; Wang C.-H.; HWEI-FANG TIEN | Journal of the Formosan Medical Association | 7 | 6 | |
23 | 2012 | Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010 | Chen, Chien-Yuan ; SHANG-YI HUANG ; WOEI TSAY ; MING YAO ; JIH-LUH TANG ; BOR-SHENG KO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 28 | 22 | |
24 | 2013 | Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10 | Chen, Chien-Yuan ; SHANG-YI HUANG ; JIH-LUH TANG ; WOEI TSAY ; MING YAO ; BOR-SHENG KO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 26 | 25 | |
25 | 2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 123 | 100 | |
26 | 2006 | Clinical implications of SOCS1 methylation in myelodysplastic syndrome | SHANG-JU WU ; MING YAO ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Chen, Chien-Yuan ; BOR-SHENG KO ; Huang S.-Y.; WOEI TSAY ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN | British Journal of Haematology | 35 | 29 | |
27 | 2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
28 | 2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 57 | 42 | |
29 | 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
30 | 2022 | A Coarse-to-Fine Pathology Patch Selection for Improving Gene Mutation Prediction in Acute Myeloid Leukemia | Chiu, Chun-Chia; Li, Jeng-Lin; Wang, Yu-Fen; BOR-SHENG KO ; Lee, Chi-Chun | Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference | 1 | 0 | |
31 | 2008 | Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies | TAI-CHUNG HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; CHIUN HSU ; Chen, Chien-Yuan ; WOEI TSAY ; SHANG-YI HUANG ; MING YAO ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; HWEI-FANG TIEN | Leukemia | 47 | 42 | |
32 | 2017 | Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity | Liang S.-M.; Lu Y.-J.; BOR-SHENG KO ; Jan Y.-J.; Shyue S.-K.; Yet S.-F.; Liou J.-Y. | Scientific Reports | 25 | 18 | |
33 | 2013 | Cordycepin Regulates GSK-3β/β-Catenin Signaling in Human Leukemia Cells | BOR-SHENG KO ; Lu Y.-J.; Yao W.-L.; Liu T.-A.; Tzean S.-S.; Shen T.-L.; Liou J.-Y. | PLoS ONE | 37 | 36 | |
34 | 2019 | Cordycepin suppresses endothelial cell proliferation, migration, angiogenesis, and tumor growth by regulating focal Adhesion Kinase and p53 | Lin Y.-T.; Liang S.-M.; Wu Y.-J.; Wu Y.-J.; Lu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Chuang Y.-J.; Shyue S.-K.; Kuo C.-C.; Liou J.-Y. | Cancers | 15 | 13 | |
35 | 2014 | Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular Carcinoma | Yao W.-L.; BOR-SHENG KO ; Liu T.-A.; Liang S.-M.; Liu C.-C.; Lu Y.-J.; Tzean S.-S.; Shen T.-L.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 42 | 36 | |
36 | 2020 | Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan | Wang, Yu-Hung; SHAN-CHI YU ; BOR-SHENG KO ; YI-TSUNG YANG ; MING YAO ; JIH-LUH TANG ; TAI-CHUNG HUANG | International journal of hematology | 3 | 3 | |
37 | 2007 | Cyclooxygenase-2-derived prostaglandin E2 protects mouse embryonic stem cells from apoptosis | Liou J.-Y.; Ellent D.P.; Lee S.; Goldsby J.; BOR-SHENG KO ; Matijevic N.; Huang J.-C.; Wu K.K. | Stem Cells | 61 | 56 | |
38 | 2011 | Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B | Chiang L.-T.; MING YAO ; BOR-SHENG KO ; CHIEN-HUNG CHEN | Infection | 4 | 5 | |
39 | 2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 179 | 173 | |
40 | 2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 174 | 160 | |
41 | 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 5 | 6 | |
42 | 2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
43 | 2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 195 | 184 | |
44 | 2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | MING-EN LIN ; HSIN-AN HOU ; CHENG-HONG TSAI ; SHANG-JU WU ; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; Li C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin C.-T.; HWEI-FANG TIEN | Clinical Epigenetics | 30 | 25 | |
45 | 2024 | Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations | FENG-MING TIEN ; CHI-YUAN YAO ; Tsai, Xavier Cheng-Hong; Lo, Min-Yen; Chen, Chien-Yuan; WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Peng, Yen-Ling; Tseng, Mei-Hsuan; Wu, Yu-Sin; Liu, Ming-Chih; LIANG-IN LIN ; MING-KAI CHUANG ; BOR-SHENG KO ; MING YAO ; Tang, Jih-Luh; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 0 | ||
46 | 2020 | Economic burden of cancers in Taiwan: A direct and indirect cost estimate for 2007-2017 | Huang S.-Y.; Chen H.-M.; Liao K.-H.; BOR-SHENG KO ; FEI-YUAN HSIAO | BMJ Open | 16 | 16 | |
47 | 2010 | An efficient transfection method for mouse embryonic stem cells | Liou, Jun-Yang; BOR-SHENG KO ; Chang, Tzu-Ching | Methods in molecular biology (Clifton, N.J.) | 9 | 0 | |
48 | 2009 | An efficient transfection method for mouse embryonic stem cells | BOR-SHENG KO ; Chang T.C.; Shyue S.K.; YAO-CHANG CHEN ; Liou J.Y. | Gene Therapy | 20 | 17 | |
49 | 2021 | Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015 | BOR-SHENG KO ; Chen L.-J.; HUAI-HSUAN HUANG ; Chen H.-M.; FEI-YUAN HSIAO | International Journal of Clinical Practice | 9 | 6 | |
50 | 2022 | The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan | HUAI-HSUAN HUANG ; Chen C.-M.; Wang C.-Y.; Hsu W.W.-Y.; Chen H.-M.; BOR-SHENG KO ; FEI-YUAN HSIAO | PLoS ONE | 4 | 4 | |
51 | 2020 | Expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasia | Lu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Liang S.-M.; Chen L.; CHIH-CHENG WU ; Chin C.-H.; Kuo C.-C.; Yet S.-F.; Liou J.-Y. | Aging | 12 | 12 | |
52 | 2013 | Expression of partitioning defective 3 (Par-3) for predicting extrahepatic metastasis and survival with hepatocellular carcinoma | Jan Y.-J.; BOR-SHENG KO ; Liu T.-A.; YAO-MING WU ; Liang S.-M.; Chen S.-C.; Wang J.; Liou J.-Y. | International Journal of Molecular Sciences | 23 | 20 | |
53 | 1999 | Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - The occurrence of retinoic acid syndrome is a risk factor | BOR-SHENG KO ; JIH-LUH TANG ; YAO-CHANG CHEN ; MING YAO ; Wang C.-H.; MING-CHING SHEN ; HWEI-FANG TIEN | Leukemia | 77 | 61 | |
54 | 2020 | Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis | Liao K.-H.; BOR-SHENG KO ; Chen L.-K.; FEI-YUAN HSIAO | Clinical and Translational Science | 2 | 2 | |
55 | 2010 | Focal Adhesion Kinase as a Therapeutic Target of Bortezomib | BOR-SHENG KO ; Chang T.-C.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 6 | 6 | |
56 | 2020 | Frontline treatments in extremely elderly patients with diffuse large B-cell lymphoma: A population-based study in Taiwan, 2010-2015 | HUAI-HSUAN HUANG ; BOR-SHENG KO ; Chen H.-M.; Chen L.-J.; Wang C.-Y.; Hsiao F.-Y.; FEI-YUAN HSIAO | Immunity and Ageing | 5 | 5 | |
57 | 2005 | Gastrointestinal: Burkitt's lymphoma | JYH-MING LIOU ; HSIU-PO WANG ; BOR-SHENG KO ; TSU-YAO CHENG ; MING-SHIANG WU ; Lin J.-T. | Journal of Gastroenterology and Hepatology (Australia) | 7 | 8 | |
58 | 2015 | GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution | HSIN-AN HOU ; YUN-CHU LIN ; Kuo Y.-Y.; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Annals of Hematology | 21 | 20 | |
59 | 2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chiu, Yu-Chiao; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; LIANG-IN LIN ; Lin, Chien-Ting; SHANG-JU WU ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-YI HUANG ; MING YAO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 29 | ||
60 | 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | CHENG-HONG TSAI ; HSIN-AN HOU ; JIH-LUH TANG ; Liu, C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, M.-H.; Chiang, Y.-C.; Kuo, Y.-Y.; Liu, M.-C.; Liu, C.-W.; LIANG-IN LIN ; WOEI TSAY ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; HWEI-FANG TIEN | Leukemia | 100 | 90 | |
61 | 2022 | Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma | Chieh-Lung Cheng ; Fang, Wei-Quan; YU-JEN LIN ; CHANG-TSU YUAN ; BOR-SHENG KO ; JIH-LUH TANG ; HWEI-FANG TIEN | Journal of cancer research and clinical oncology | 4 | 3 | |
62 | 2015 | High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan | JIH-LUH TANG ; HSIANG-CHI KUNG ; Lei W.-C.; MING YAO ; UN-IN WU ; SZU-CHUN HSU ; Lin C.-T.; Li C.-C.; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG ; BOR-SHENG KO ; HWEI-FANG TIEN | PLoS ONE | 48 | 42 | |
63 | 2015 | Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study | SHANG-YI HUANG ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; HSIN-AN HOU ; WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; SZU-CHUN HSU ; BOR-SHENG KO ; Lu H.-Y.; WOEI TSAY ; HWEI-FANG TIEN | PLoS ONE | 10 | 9 | |
64 | 2005 | Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking | Huang, Dong-Ming; Hung, Yann; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Wei-Hsuan; CHUNG-LIANG CHIEN ; Tsai, Chih-Pin; Kuo, Chieh-Ti; Kang, Ju-Chiun; Yang, Chung-Shi; Mou, Chung-Yuan; YAO-CHANG CHEN | FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 289 | 272 | |
65 | 2009 | HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia | SHANG-JU WU ; MING YAO ; JIH-LUH TANG ; BOR-SHENG KO ; HWEI-FANG TIEN ; YAO-CHANG CHEN | Journal of the Formosan Medical Association | 2 | 2 | |
66 | 2010 | Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells. | Chang M.; Hsiao J.K.; MING YAO ; Chien L.Y.; SZU-CHUN HSU ; BOR-SHENG KO ; Chen S.T.; HON-MAN LIU ; YAO-CHANG CHEN ; Yang C.S.; Huang D.M. | Nanotechnology | 28 | 27 | |
67 | 2018 | Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Li, Chi-Cheng; Lin, Chien-Ting; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | European Journal of Haematology | 29 | 23 | |
68 | 2023 | Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Miklos, David Bernard; Abu Zaid, Mohammad; Cooney, Julian P; Albring, Jörn C; Flowers, Mary; Skarbnik, Alan P; Yakoub-Agha, Ibrahim; BOR-SHENG KO ; Bruno, Benedetto; Waller, Edmund K; Yared, Jean; Sohn, Sang Kyun; Bulabois, Claude-Eric; Teshima, Takanori; Jacobsohn, David; Greinix, Hildegard; Mokatrin, Ahmad; Lee, Yihua; Wahlstrom, Justin T; Styles, Lori; Socie, Gerard | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 12 | 4 | |
69 | 2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; Liu C.-Y.; Chen, Chien-Yuan ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 74 | 69 | |
70 | 2020 | Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program | FEN-YU TSENG ; Lin, Lung-Chun ; BOR-SHENG KO ; TZONG-SHINN CHU ; SHIH-LI TSAI ; WANG-HUEI SHENG ; CHUNG-JEN YEN ; CHIA-HSUIN CHANG ; CHENG-HAN WU ; SHYANG-RONG SHIH ; WEI-YIH CHIU ; SUNG-CHING PAN ; Chen, Wei-Ping; PO-YUAN CHANG | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | 0 | |
71 | 2011 | Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma | Liu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Chen S.-C.; Liang S.-M.; Hung Y.-L.; CHIUN HSU ; TANG-LONG SHEN ; Lee Y.-M.; Chen P.-F.; Wang J.; Shyue S.-K.; Liou J.-Y. | American Journal of Pathology | 38 | 38 | |
72 | 2010 | The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells | YAO-CHANG CHEN ; Hsiao J.-K.; HON-MAN LIU ; Lai I.-Y.; MING YAO ; SZU-CHUN HSU ; BOR-SHENG KO ; Yang C.-S.; Huang D.-M. | Toxicology and Applied Pharmacology | 146 | 148 | |
73 | 2014 | Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia | HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; JIH-LUH TANG ; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; LIANG-IN LIN ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia | 75 | 73 | |
74 | 2011 | Involvement of 14-3-3γ overexpression in extrahepatic metastasis of hepatocellular carcinoma | BOR-SHENG KO ; I-RUE LAI ; Chang T.-C.; Liu T.-A.; Chen S.-C.; Wang J.; Jan Y.-J.; Liou J.-Y. | Human Pathology | 30 | 24 | |
75 | 2014 | IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients | YI-TSUNG YANG ; HSIN-AN HOU ; Liu C.-Y.; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG ; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Lin C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 19 | 16 | |
76 | 2022 | Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study | Jang, Jun Ho; Wong, Lily; BOR-SHENG KO ; Yoon, Sung-Soo; Li, Katie; Baltcheva, Irina; Nidamarthy, Prasanna Kumar; Chawla, Raghav; Junge, Guido; Yap, Eng Soo | Blood advances | 15 | 11 | |
77 | 2005 | Isolation of multipotent cells from human term placenta | Yen B.L.; Huang H.-I.; Chien C.-C.; Jui H.-Y.; BOR-SHENG KO ; MING YAO ; CHIA-TUNG SHUN ; MEN-LUH YEN ; Lee M.-C.; YAO-CHANG CHEN | Stem Cells | 409 | 336 | |
78 | 2012 | A Knock-In Npm1 Mutation in Mice Results in Myeloproliferation and Implies a Perturbation in Hematopoietic Microenvironment | Chou S.-H.; BOR-SHENG KO ; Chiou J.-S.; Hsu Y.-C.; MONG-HSUN TSAI ; Chiu Y.-C.; Yu I.-S.; SHU-WHA LIN ; HSIN-AN HOU ; Kuo Y.-Y.; Lin H.-M.; Wu M.-F.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | PLoS ONE | 20 | 17 | |
79 | 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 41 | 34 | |
80 | 2009 | Long-term outcome of allogeneic human leukocyte antigen-matched sibling-donor peripheral blood stem cell transplantation in leukaemia patients | JIH-LUH TANG ; MING YAO ; MENG-YAO LU ; BOR-SHENG KO ; Lin D.T.; KAI-HSIN LIN ; YEN-CHING CHEN | Hong Kong Medical Journal | 1 | 0 | |
81 | 2019 | Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan | BOR-SHENG KO ; Chang M.-C.; Chiou T.-J.; Chang T.-K.; Chen Y.-C.; Lin S.-F.; Chang C.-S.; Lu Y.-C.; Yeh S.-P.; Chen T.-Y.; Hwang W.-S. | Hematology (United Kingdom) | 5 | 4 | |
82 | 2007 | Lymph nodes in gastrointestinal tract | TSUNG-CHUN LEE ; BOR-SHENG KO ; CHIA-TUNG SHUN ; Lin J.-T.; Spiller R.; HSIU-PO WANG | Gut | 0 | 0 | |
83 | 2023 | Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death | CHIH-PENG LIN ; Wu, Shu-Hui; Lin, Tzu-Yin; Chu, Chia-Hui; Lo, Leu-Wei; Kuo, Ching-Chuan; Chang, Jang-Yang; SZU-CHUN HSU ; BOR-SHENG KO ; MING YAO ; Hsiao, Jong-Kai; Wang, Shih-Wei; Huang, Dong-Ming | Pharmacological research | 0 | 0 | |
84 | 2022 | A Machine Learning Approach to the Classification of Acute Leukemias and Distinction From Nonneoplastic Cytopenias Using Flow Cytometry Data | Monaghan S.A.; Li J.-L.; Liu Y.-C.; Ko M.-Y.; Boyiadzis M.; Chang T.-Y.; Wang Y.-F.; Lee C.-C.; Swerdlow S.H.; BOR-SHENG KO | American Journal of Clinical Pathology | 12 | 4 | |
85 | 2022 | Outcomes of Different Haploidentical Transplantation Strategies from the Taiwan Blood and Marrow Transplantation Registry | CHENG-HONG TSAI ; Chen, Tzu-Ting; Gau, Jyh-Pyng; Wang, Po-Nan; Liu, Yi-Chang; Lien, Ming-Yu; Li, Chi-Cheng; MING YAO ; BOR-SHENG KO | Cancers | 5 | 4 | |
86 | 2009 | Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma | Jan Y.-J.; BOR-SHENG KO ; CHIUN HSU ; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y. | Human Pathology | 28 | 27 | |
87 | 2011 | Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma | BOR-SHENG KO ; Chang T.-C.; CHIUN HSU ; YAO-CHANG CHEN ; Shen T.-L.; Chen S.-C.; Wang J.; Wu K.K.; Jan Y.-J.; Liou J.-Y. | Histopathology | 48 | 46 | |
88 | 2016 | Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinoma-secreted 14-3-3s | Liu C.-C.; Chang T.-C.; Lin Y.-T.; Yu Y.-L.; BOR-SHENG KO ; Sung L.-Y.; Liou J.-Y. | Oncotarget | 13 | 14 | |
89 | 2001 | Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan | BOR-SHENG KO ; JIH-LUH TANG ; Tsai W.; YAO-CHANG CHEN ; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; HWEI-FANG TIEN | Annals of Hematology | 10 | 10 | |
90 | 2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 10 | 9 | |
91 | 2021 | Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan | Hung Y.-C.; Gau J.-P.; SHANG-YI HUANG ; BOR-SHENG KO ; Teng C.-L.J. | Frontiers in Oncology | 0 | 0 | |
92 | 2009 | Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute | HSIN-AN HOU ; MING YAO ; JIH-LUH TANG ; YIN-KAI CHEN ; BOR-SHENG KO ; Huang S.-Y.; HWEI-FANG TIEN ; HSIU-HAO CHANG ; MENG-YAO LU ; TING TSE LIN ; Lin K.-H.; Hsiao C.-H.; CHUNG-WU LIN ; YAO-CHANG CHEN | Bone Marrow Transplantation | 45 | 38 | |
93 | 2023 | Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML | CHENG-HONG TSAI ; Sun, Kuo-Jui; Lo, Min-Yen; FENG-MING TIEN ; YUAN-YEH KUO ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; Sun, Hsun-I; Liu, Ming-Chih; CHIA-WEN LIU ; CHIEN-CHIN LIN ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 5 | 3 | |
94 | 2011 | The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia | WEN-CHIEN CHOU ; Lei W.-C.; BOR-SHENG KO ; HSIN-AN HOU ; Chen C.-Y.; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 132 | 132 | |
95 | 2014 | Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations | SHENG-CHIEH CHOU ; JIH-LUH TANG ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Hu F.-C.; Chen, Chien-Yuan ; MING YAO ; BOR-SHENG KO ; SHANG-YI HUANG ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Leukemia Research | 18 | 18 | |
96 | 2018 | Prognostic significance of 14-3-3ε, aldo-keto reductase family 1 B10 and metallothionein-1 in hepatocellular carcinoma | Wu C.-Y.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-J.; Wu Y.-J.; Liou J.-Y. | Anticancer Research | 5 | 3 | |
97 | 2009 | The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles | Huang D.-M.; Hsiao J.-K.; YAO-CHANG CHEN ; Chien L.-Y.; MING YAO ; YIN-KAI CHEN ; BOR-SHENG KO ; SZU-CHUN HSU ; Tai L.-A.; Cheng H.-Y.; Wang S.-W.; Yang C.-S. | Biomaterials | 293 | 277 | |
98 | 2021 | Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015 | Wang C.-Y.; HUAI-HSUAN HUANG ; Chen H.-M.; FEI-YUAN HSIAO ; BOR-SHENG KO | Clinical Lymphoma, Myeloma and Leukemia | 1 | 0 | |
99 | 2023 | Recommendations for the treatment and management of adult B-Cell acute lymphoblastic leukemia in Asia-Pacific: Outcomes from a pilot initiative | Lao, Zhentang; Lam, Kwong Yok; Cheung, Yuk Man Carol; Teng, Chieh-Lin; Radhakrishnan, Vivek; Bhurani, Dinesh; BOR-SHENG KO ; Goh, Yeow Tee | Asia-Pacific journal of clinical oncology | |||
100 | 2021 | Reduced expression of metallothionein-i/ii in renal proximal tubules is associated with advanced chronic kidney disease | Lu Y.-J.; Wu Y.-J.; Chen L.-J.; BOR-SHENG KO ; Chang T.-C.; Wu Y.-J.; Liang S.-M.; Jan Y.-J.; Liou J.-Y. | Toxins | 2 | 2 | |
101 | 2016 | Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation | YUN CHIANG ; CHENG-HONG TSAI ; SUNG-HSIN KUO ; Liu, Chieh-Yu; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; Lin, Chien-Ting; HSIN-AN HOU ; WEN-CHIEN CHOU ; JIA-HAU LIU ; CHIEN-CHIN LIN ; SHANG-JU WU ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; YUNG-LI YANG ; HSIU-HAO CHANG ; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; SHENG-CHIEH CHOU ; Chieh-Lung Cheng ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN ; JIH-LUH TANG ; YU-HSUAN CHEN | Scientific Reports | 18 | 15 | |
102 | 2003 | Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | SHANG-YI HUANG ; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO ; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; HWEI-FANG TIEN ; MING-CHING SHEN ; YAO-CHANG CHEN | Annals of Hematology | 12 | 10 | |
103 | 2015 | Regulation of Aldo-keto-reductase family 1 B10 by 14-3-3∈ and their prognostic impact of hepatocellular carcinoma | Liu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Wu Y.-J.; Lu Y.-J.; Liang S.-M.; Liu C.-C.; Chen S.-C.; Wang J.; Shyue S.-K.; Liou J.-Y. | Oncotarget | 18 | 17 | |
104 | 2018 | Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial | Lin C.-T.; PO-REN HSUEH ; SHANG-JU WU ; MING YAO ; BOR-SHENG KO ; Li C.-C.; Hsu C.-A.; JIH-LUH TANG ; HWEI-FANG TIEN | Biology of Blood and Marrow Transplantation | 4 | 3 | |
105 | 2010 | Rho kinases regulate the renewal and neural differentiation of embryonic stem cells in a cell plating density-dependent manner | Chang T.-C.; Chen Y.-C.; Yang M.-H.; Chen C.-H.; Hsing E.-W.; BOR-SHENG KO ; Liou J.-Y.; Wu K.K. | PLoS ONE | 29 | 27 | |
106 | 2015 | Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells | Cheng, Ya-Ting; Yeih, Dong-Feng; Liang, Shu-Man; Chien, Chia-Ying; Yu, Yen-Ling; BOR-SHENG KO ; Jan, Yee-Jee; Kuo, Cheng-Chin; Sung, Li-Ying; Shyue, Song-Kun; MING-FONG CHEN ; Yet, Shaw-Fang; Wu, Kenneth K.; Liou, Jun-Yang | International Journal of Cardiology | 12 | 11 | |
107 | 2023 | Risk of thromboembolic events associated with different multiple myeloma regimens in Taiwan: a nested case-control study | Chen, Mei-Tsen; Huang, Shih-Tsung; HUAI-HSUAN HUANG ; WEN-JONE CHEN ; BOR-SHENG KO ; Hsiao, Fei-Yuan | Journal of thrombosis and thrombolysis | 1 | 0 | |
108 | 2018 | Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real-world analysis from Taiwan Cancer Registry Database | HUAI-HSUAN HUANG ; Wen Y.-C.; Chen H.-M.; FEI-YUAN HSIAO ; BOR-SHENG KO | Cancer Medicine | 6 | 5 | |
109 | 2007 | RUNX1 gene mutation in primary myelodysplastic syndrome - The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome | Chen, Chien-Yuan ; LIANG-IN LIN ; JIH-LUH TANG ; BOR-SHENG KO ; WOEI TSAY ; WEN-CHIEN CHOU ; MING YAO ; SHANG-JU WU ; Tseng M.-H.; HWEI-FANG TIEN | British Journal of Haematology | 115 | 106 | |
110 | 2007 | Severe pulmonary complications after initial treatment with rituximab for the Asian-variant of intravascular lymphoma | SHANG-JU WU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; HWEI-FANG TIEN | Haematologica | 29 | 30 | |
111 | 2014 | SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution | CHIEN-CHIN LIN ; HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo Y.-Y.; SHANG-JU WU ; Liu C.-Y.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; SZU-CHUN HSU ; BOR-SHENG KO ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 30 | 26 | |
112 | 2016 | Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia | HSIN-AN HOU ; Liu, Chieh-Yu; Kuo, Yuan-Yeh; WEN-CHIEN CHOU ; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; LIANG-IN LIN ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; JIH-LUH TANG ; MING YAO ; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, Chien-Ting; SHANG-JU WU ; WOEI TSAY ; HWEI-FANG TIEN | Oncotarget | 67 | 62 | |
113 | 2022 | Stem cell transplant for mantle cell lymphoma in Taiwan | Wang Y.-H.; Hsieh C.-Y.; Hsiao L.-T.; Lin T.-L.; Liu Y.-C.; MING YAO ; Tan T.-D.; BOR-SHENG KO | Scientific Reports | 1 | 0 | |
114 | 2018 | Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002-2012 | BOR-SHENG KO ; Chen L.-J.; HUAI-HSUAN HUANG ; Wen Y.-C.; Liao C.-Y.; Chen H.-M.; FEI-YUAN HSIAO | Cancer Medicine | 12 | 8 | |
115 | 2024 | Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan | Huang, Yi-Che; Hsiao, Fei-Yuan; Guan, Shang-Ting; MING YAO ; Liu, Chia-Jen; Chen, Tzu-Ting; Lin, Tung-Liang; Liu, Yi-Chang; Chen, Tsai-Yun; Hong, Ying-Chung; Ma, Ming-Chun; Tan, Tran-Der; Wang, Chuan-Cheng; Wu, Yi-Ying; Liao, Po-Wei; Wu, Yi-Feng; Chen, Yi-Yang; Yu, Yuan-Bin; Hsieh, Yao-Yu; Lee, Ming-Yang; Liu, Jia-Hau; Lin, Shu-Wen; BOR-SHENG KO | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | |||
116 | 2011 | TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | WEN-CHIEN CHOU ; SHENG-CHIEH CHOU ; Liu C.-Y.; Chen, Chien-Yuan ; HSIN-AN HOU ; Kuo Y.-Y.; Lee M.-C.; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Chang Y.-C.; Kuo Y.-Y.; KUAN-TING KUO ; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 255 | 235 | |
117 | 2015 | TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution | HSIN-AN HOU ; WEN-CHIEN CHOU ; Kuo, Y.-Y.; Liu, C.-Y.; LIANG-IN LIN ; Tseng, M.-H.; Chiang, Y.-C.; Liu, M.-C.; Liu, C.-W.; JIH-LUH TANG ; MING YAO ; Li, C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Chen, Chien-Yuan ; Lin, C.-T.; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood Cancer Journal | 112 | 111 | |
118 | 2021 | Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population-Based, Propensity Score-Matched Cohort Study | Chen, Mei-Tsen; Huang, Shih-Tsung; Lin, Chih-Wan; BOR-SHENG KO ; WEN-JONE CHEN ; HUAI-HSUAN HUANG ; FEI-YUAN HSIAO | The oncologist | 7 | 5 | |
119 | 2013 | Upregulation of Focal adhesion kinase by 14-3-3ε via NFκB activation in Hepatocellular Carcinoma | BOR-SHENG KO ; Jan Y.-J.; Chang T.-C.; Liang S.-M.; Chen S.-C.; Liu T.-A.; YAO-MING WU ; Wang J.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 28 | 23 | |
120 | 2023 | Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia | Lo, Min-Yen; Tsai, Xavier Cheng-Hong; CHIEN-CHIN LIN ; FENG-MING TIEN ; Kuo, Yuan-Yeh; WAN-HSUAN LEE ; Peng, Yen-Ling; Liu, Ming-Chih; Tseng, Mei-Hsuan; Hsu, Cheng-An; JUI-CHE CHEN ; LIANG-IN LIN ; Sun, Hsun-I; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 4 | 4 | |
121 | 2019 | Women with diffuse large B cell lymphoma benefit more from rituximab-containing chemotherapy | HUAI-HSUAN HUANG ; FEI-YUAN HSIAO ; Chen L.-J.; Chen H.-M.; BOR-SHENG KO | Journal of Women's Health | 5 | 6 | |
122 | 2010 | WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system | HSIN-AN HOU ; TAI-CHUNG HUANG ; LIANG-IN LIN ; Liu C.-Y.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 142 | 137 | |
123 | 2019 | ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma | Wu Y.-J.; BOR-SHENG KO ; Liang S.-M.; Lu Y.-J.; Jan Y.-J.; Jiang S.-S.; Shyue S.-K.; Chen L.; Liou J.-Y. | Cell Death and Disease | 16 | 14 |